Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Chola Securities’ Dharmesh Kant bets on banks, power; cautions on consumer valuations
Dharmesh Kant, Head Research at Chola Securities, says India's growth outlook remains strong, driven by robust demand, infrastructure execution and healthy credit growth. He remains positive on power equipment after further correction, prefers select private and PSU banks, sees value in pharma and hospitals, and is constructive on Mumbai-focused real estate. However, he advises caution on richly valued consumer stocks despite improving business fundamentals.
Dividend alert! Last day to buy JSW Steel, Sun Pharma, 4 more stocks to earn payouts up to Rs 75
JSW Steel has fixed Tuesday as the record date for its final dividend of Rs 7.1 per share for the financial year 2026. Once approved by the shareholders during its upcoming Annual General Meeting (AGM), the said dividend will be paid within 30 days from the date of its declaration, the company said.
Record Date Alert: 15 companies set to see corporate actions for dividend, bonus this week
More than 15 stocks, including multiple Nifty 50 constituents, such as Titan, Hindalco, JSW Steel, and Sun Pharma are set to see record dates for their respective corporate actions announced earlier, alongside their fourth quarter results. While most of these corporate actions pertain to final dividend announcements, some also include bonus issue awards as well.
Elara Securities turns bullish on banks, power, IT after market correction
Bino Pathiparampil, Head of Research, Elara Securities (India), says Indian markets are nearing a medium-term bottom after a prolonged correction and is turning constructive on banks, power, select new-age companies, IT and real estate. While pharma remains a defensive bet, he expects margin pressure to limit near-term outperformance. He also believes IT stocks are gradually pricing in AI-led headwinds, making it a good time to start accumulating quality names.
Sun Pharma to acquire 100% stake in Innovcare Lifesciences for Rs 271 crore
Sun Pharmaceutical Industries said that it has entered into an agreement for acquiring 100% outstanding shares of Innovcare Lifesciences for a total consideration of Rs 271.2 crore.
Stock Alert: Sun Pharma, GRSE, GE Power, Goodluck India, Zaggle Prepaid, Texmaco Rail - Business Standard
Stock Alert: Sun Pharma, GRSE, GE Power, Goodluck India, Zaggle Prepaid, Texmaco RailBusiness Standard
Sun Pharma Q4 results 2026: Profit jumps 26% YoY to ₹2,714 crore; recommends final dividend of ₹5 for FY26
Sun Pharma Q4 results 2026: Profit jumped 26% YoY to ₹2,714 crore. Total revenue from operations for the quarter under review rose 12.8% YoY to ₹14,611.79 crore. Sun Pharma's board recommended a final dividend of ₹5 per share of ₹l each.
Q4 Results LIVE Updates: Sanghvi Movers shares surge over 12%; Jubilant Foodworks down 7%
Q4 Results LIVE Updates: ITC, Aurobindo Pharma, LIC, LG Electronics, Ashoka Buildcon, Bikaji Foods, Datamatics, Engineers India, GMM Pfaudler, Happy Forgings, Honasa Consumer, Ixigo, Nykaa, Page Industries, Ramco Cements, Max Healthcare, Prestige Estates, MTNL, Sun TV, Quick Heal, RCF, WeWork, VA Tech Wabag, are among the companies reporting their earnings today. The street will also react to numbers reported by Whirlpool, Apollo Hospitals, Sammaan Capital, JK Lakshmi Cement, Lenskart, Ola Electric and others. Watch this space for all the LIVE earnings updates.
Sun Pharmaceutical receives credit ratings from CRISIL and ICRA
Sun Pharmaceutical Industries (Sun Pharma) announced that CRISIL has reaffirmed the rating of the company's long term bank facilities at CRISIL AAA and short term bank facilities and commercial paper at CRISIL A1+.
Sun Pharma, 5 stocks hit 52-week highs, rally up to 25% in a month
Sensex surged 940 points as six BSE 100 stocks hit 52-week highs, signalling strong bullish momentum. Stocks like Adani Ports, Nestle India and Sun Pharma led gains, supported by solid monthly performance and positive investor sentiment in a rising market
Sun Pharma Dividend Update: What 6.6 lakh retail holders need to know after Organon deal
At the end of the March quarter, Sun Pharma had a total of 6.6 lakh small retail shareholders, or those with an authorized share capital of up to ₹2 lakh. Starting February 2022, shareholders of Sun Pharma have received ₹62 per share as dividend payouts.
Sun Pharma a trading play on dips, banks may face difficult June quarter: Dharmesh Kant
Dharmesh Kant, Head of Research at Chola Securities, said Sun Pharma’s all-cash acquisition of Organon could improve return ratios and support valuations, but may bring overall revenue growth down to single digits. He sees a trading opportunity in Sun Pharma on price dips. On banking, he said Q1 could be difficult as provisioning picks up, which may weigh on profitability even as asset quality and margins remain stable. Disclaimer: The views and tips expressed by investment experts on CNBCTV18.com are their own, not of the website or its management. CNBCTV18.com advises users to check with certified experts before taking any investment decisions.